Show simple item record

Salivary epigenetic biomarkers as predictors of emerging childhood obesity

dc.contributor.authorRushing, Amanda
dc.contributor.authorSommer, Evan C.
dc.contributor.authorZhao, Shilin
dc.contributor.authorPo'e, Eli K.
dc.contributor.authorBarkin, Shari L.
dc.date.accessioned2020-10-22T19:46:09Z
dc.date.available2020-10-22T19:46:09Z
dc.date.issued2020-02-14
dc.identifier.citationRushing, A., Sommer, E. C., Zhao, S., Po'e, E. K., & Barkin, S. L. (2020). Salivary epigenetic biomarkers as predictors of emerging childhood obesity. BMC medical genetics, 21(1), 34. https://doi.org/10.1186/s12881-020-0968-7en_US
dc.identifier.othereISSN: 1471-2350
dc.identifier.urihttp://hdl.handle.net/1803/16248
dc.description.abstractBackground Epigenetics could facilitate greater understanding of disparities in the emergence of childhood obesity. While blood is a common tissue used in human epigenetic studies, saliva is a promising tissue. Our prior findings in non-obese preschool-aged Hispanic children identified 17 CpG dinucleotides for which differential methylation in saliva at baseline was associated with maternal obesity status. The current study investigated to what extent baseline DNA methylation in salivary samples in these 3-5-year-old Hispanic children predicted the incidence of childhood obesity in a 3-year prospective cohort. Methods We examined a subsample (n = 92) of Growing Right Onto Wellness (GROW) trial participants who were randomly selected at baseline, prior to randomization, based on maternal phenotype (obese or non-obese). Baseline saliva samples were collected using the Oragene DNA saliva kit. Objective data were collected on child height and weight at baseline and 36 months later. Methylation arrays were processed using standard protocol. Associations between child obesity at 36 months and baseline salivary methylation at the previously identified 17 CpG dinucleotides were evaluated using multivariable logistic regression models. Results Among the n = 75 children eligible for analysis, baseline methylation of Cg1307483 (NRF1) was significantly associated with emerging childhood obesity at 36-month follow-up (OR = 2.98, p = 0.04), after adjusting for child age, gender, child baseline BMI-Z, and adult baseline BMI. This translates to a model-estimated 48% chance of child obesity at 36-month follow-up for a child at the 75th percentile of NRF1 baseline methylation versus only a 30% chance of obesity for a similar child at the 25th percentile. Consistent with other studies, a higher baseline child BMI-Z during the preschool period was associated with the emergence of obesity 3 years later, but baseline methylation of NRF1 was associated with later obesity even after adjusting for child baseline BMI-Z. Conclusions Saliva offers a non-invasive means of DNA collection and epigenetic analysis. Our proof of principle study provides sound empirical evidence supporting DNA methylation in salivary tissue as a potential predictor of subsequent childhood obesity for Hispanic children. NFR1 could be a target for further exploration of obesity in this population.en_US
dc.description.sponsorshipThis research was supported by grants (U01 HL103620) with additional support for the remaining members of the COPTR Consortium (U01HL103622, U01HL103561, U01HD068890, U01HL103629) from the National Heart, Lung, and Blood Institute and the Eunice Kennedy Shriver National Institute of Child Health and Development and the Office of Behavioral and Social Sciences Research. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Heart, Lung, And Blood Institute, the National Institutes of Health, or the National Institute of Child Health and Development. This research was also supported by grants 5P30DK092986-03 from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) and 5UL1TR0045 from the Vanderbilt Institute for Clinical and Translational Research (VICTR). The NHLBI and NICHD played an advisory role in all phases of the study, including the design and conduct of the study; collection, analysis, and interpretation of the data; and in writing the manuscript.en_US
dc.language.isoen_USen_US
dc.publisherBMC Medical Geneticsen_US
dc.subjectObesityen_US
dc.subjectHispanic childrenen_US
dc.subjectEpigeneticsen_US
dc.subjectMethylationen_US
dc.subjectSalivaen_US
dc.titleSalivary epigenetic biomarkers as predictors of emerging childhood obesityen_US
dc.typeArticleen_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record